Okay, maybe those doctoral economists will come in handy. Jokes aside, bringing life-saving drugs to market will never be cheap – and it will require government participation.
However, there’s a difference between red tape syphoning better-spent dollars to line the pockets of insurance companies who DON’T actually care for our population, and making sure a drug company developing an Alzheimer’s treatment can recoup their billion dollar investment.